{"entity":{"id":"src-biopharma-dive","kind":"collection","name":"BioPharma Dive","aka":[],"tldr":"BioPharma Dive offers clean, free industry reporting and is good for deal and approval context.","summary":"BioPharma Dive offers clean, free industry reporting on approvals, trial results, mergers and acquisitions and policy, and is good for deal and approval context. It publishes daily and is run by Industry Dive, part of Informa. Access is free without a paywall, which sets it apart from the subscription industry titles. On OnCo it is listed as a source with the tags source and news, read for the industry side of oncology and for context on deals and approvals when a free explainer is needed.","asOf":"2026-09-08","links":[{"label":"BioPharma Dive","url":"https://www.biopharmadive.com/"}],"tags":["source","news"],"related":[],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"url":"https://www.biopharmadive.com/","holds":"Industry news: approvals, trial results, M&A, policy.","license":"Free","maintainer":"Industry Dive (Informa)"},"route":"/collections/src-biopharma-dive/","neighbours":{"company":[{"id":"emergence-therapeutics","kind":"company","name":"Emergence Therapeutics","route":"/companies/emergence-therapeutics/"},{"id":"firefly-bio","kind":"company","name":"Firefly Bio","route":"/companies/firefly-bio/"},{"id":"nimbus-therapeutics","kind":"company","name":"Nimbus Therapeutics","route":"/companies/nimbus-therapeutics/"}]}}